www.fdanews.com/articles/186435-drug-distributors-to-testify-before-congressional-panel
![Some Pills](https://www.fdanews.com/ext/resources/test/pills1.jpg?t=1578614703&width=430)
Drug Distributors to Testify Before Congressional Panel
April 17, 2018
The leaders of five drug distributors will attend a May 8 House Energy and Commerce Committee oversight panel to explain the heavy presence of their opioid products in West Virginia.
The witnesses will include executives from McKesson, Cardinal Health, AmerisourceBergen, Miami-Luken and H.D. Smith.
The committee has been investigating the activities of drug wholesalers, who are legally required to report suspicious orders of opioids to the Drug Enforcement Agency.